Doctor profile · Federal record
Dr. Brenda Sanchez, NP
Family Nurse Practitioner (CMS: Nurse Practitioner) · Spring Hill, TN
- NPI 1467806638
- Accepts Medicare
- MIPS 76.7 / 100 · 2023
- 11 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3098 Campbell Station Pkwy # A-201
Spring Hill, TN 371746270
(615) 302-5000
fax (615) 302-5005
Credentials & registration
- NPI registered
- April 2016 — 10 yrs on file
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Tennessee #21029
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1467806638. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,419
Distinct HCPCS
10
Medicare allowed
$98,298
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 865 | 155 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 430 | 293 | $71 | |
17000 |
Destruction of precancer skin growth, 1 growth | 292 | 220 | $35 | |
11102 |
Biopsy of related skin growth, first growth | 193 | 155 | $68 | |
17110 |
Destruction of skin growth, 1-14 growths | 180 | 151 | $84 | |
11103 |
Biopsy of related skin growth, each additional growth | 119 | 66 | $39 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 74 | 65 | $44 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 58 | 58 | $88 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 42 | 16 | $1 | |
11900 |
Injection into skin growth, 1-7 growths | 34 | 18 | $33 |
In context: peer comparison
Among 7 peers in Spring Hill Family Nurse Practitioner, average services per provider: 111. This provider delivers 22× the peer median.Open Payments
Industry payments received
All-time total
$3,154
Transactions
138
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 25 | $524.04 | |
| Abbvie INC. | 15 | $318.10 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 8 | $218.83 | |
| Arcutis Biotherapeutics, INC. | 4 | $214.92 | |
| Genzyme Corporation | 8 | $212.34 | |
| Novartis Pharmaceuticals Corporation | 12 | $197.59 | |
| Leo Pharma INC. | 11 | $191.78 | |
| E.R. Squibb & Sons, L.L.C. | 11 | $174.04 | |
| Incyte Corporation | 7 | $166.18 | |
| Regeneron Healthcare Solutions, INC. | 8 | $158.53 | |
| Ucb, INC. | 9 | $141.57 | |
| Lilly USA, LLC | 6 | $137.17 | |
| Amgen INC. | 5 | $127.56 | |
| Sun Pharmaceutical Industries INC. | 5 | $113.77 | |
| Galderma Laboratories, L.P. | 4 | $67.70 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
376
Patients
215
Total drug cost
$159,913
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 121 | 64 | $2,246 |
| Clobetasol Propionate | Generic | 49 | 30 | $2,603 |
| Triamcinolone Acetonide | Generic | 45 | 37 | $672 |
| Ciclopirox | Generic | 42 | 26 | $1,975 |
| Mupirocin | Generic | 37 | 30 | $340 |
| Metronidazole | Generic | 26 | 14 | $3,214 |
| Dupixent Pen (Dupilumab) | Brand | 23 | 0 | $83,577 |
| Dupixent Syringe (Dupilumab) | Brand | 17 | 0 | $63,621 |
| Fluorouracil | Generic | 16 | 14 | $1,666 |
Frequently asked questions
What is Dr. Brenda Sanchez's medical specialty?
Dr. Brenda Sanchez practices Family Nurse Practitioner in Spring Hill, TN.
Where does Dr. Brenda Sanchez practice?
Dr. Brenda Sanchez practices at 3098 Campbell Station Pkwy # A-201, Spring Hill, TN 371746270. Office phone: 6153025000.
What is Dr. Brenda Sanchez's NPI?
Dr. Brenda Sanchez's National Provider Identifier (NPI) is 1467806638, issued by NPPES.
Does Dr. Brenda Sanchez accept Medicare assignment?
Yes. Dr. Brenda Sanchez accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Brenda Sanchez commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.